Bioavailability in man of oral formulations of flunarizine (drops and capsules)
De Caro, G.; Maggi, L.
Bollettino Chimico Farmaceutico 123(10): 65S-70S
1984
ISSN/ISBN: 0006-6648 PMID: 6529492 Document Number: 241201
Document emailed within 1 workday
Related Documents
Lintz, W.; Barth, H.; Osterloh, G.; Schmidt-Böthelt, E. 1986: Bioavailability of enteral tramadol formulations. 1st communication: capsules Arzneimittel-Forschung 36(8): 1278-1283Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J. 2003: Comparative bioavailability of two oral formulations of ciprofloxacin Proceedings of the Western Pharmacology Society 46: 134-135
Lapka, R.; Cepeláková, H.; Rejholec, V.; Franc, Z. 1986: Bioavailability of two oral formulations of triazolam using radioreceptor assay Die Pharmazie 41(4): 256-257
Riaz, H.; Goodman, B.; Bashir, S.; Hussain, S.; Mahmood, S.; Malik, F.; Waseem, D.; Raza, S.A.; Mahmood, W.; Alamgeer 2016: Comparative Bioavailability Analysis of Oral Alendronate Sodium Formulations in Pakistan Acta Poloniae Pharmaceutica 73(4): 999-1007
Di Nola, F.; Soranzo, M.L. 1983: Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects Minerva Medica 74(6): 239-248
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Padeletti, L.; Brat, A. 1978: Bioavailability of digoxin in capsules International Journal of Clinical Pharmacology and Biopharmacy 16(7): 320-322
Cascioli, D.; Petrangeli, B. 1978: Drug absorption and bioavailability problems of tablets and capsules Bollettino Chimico Farmaceutico 117(8): 437-451
Suthisisang, C.; Payakachat, N. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part I: In vitro study Journal of the Medical Association of Thailand 81(1): 58-63
Suthisisang, C.; Payakachat, N.; Chulavatnatol, S.; Towanabut, S. 1998: Bioavailability of phenytoin sodium capsules available in Thailand. Part II: in vivo study Journal of the Medical Association of Thailand 81(1): 64-70
Markiewicz, A.; Semenowicz, K.; Szczyrba, E.; Kocek, B. 1978: Comparison of bioavailability of two dipyridamole formulations Polish Journal of Pharmacology and Pharmacy 30(5): 605-609
Cano, J.P.; Soliva, M.; Hartmann, D.; Ziegler, W.H.; Amrein, R. 1977: Bioavailability from various galenic formulations of flunitrazepam Arzneimittel-Forschung 27(12): 2383-2388
Verbesselt, R.; Tjandramaga, T.B.; Mullie, A.; De Schepper, P.J. 1978: Comparative bioavailability of two acebutolol formulations Bollettino Chimico Farmaceutico 117(2): 102-106
Grakovskaia, L.K.; Nesterova, L.I.; Okhotnikova, V.F.; Zak, A.F.; Ermolova, O.B. 1978: Effect of auxiliary substances on the bioavailability of tetracycline hydrochloride capsules (an in vitro study) Antibiotiki 23(3): 215-219
Okeke, I.N.; Lamikanra, A. 2001: Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community African Journal of Medicine and Medical Sciences 30(1-2): 47-51
Verin, P.; Easty, D.L.; Secchi, A.; Ciprandi, G.; Partouche, P.; Nemeth-Wasmer, G.; Brancato, R.; Harrisberg, C.J.; Estivin-Ebrardt, C.; Coster, D.J.; Apel, A.J.; Coroneo, M.T.; Knorr, M.; Carmichael, T.R.; Kent-Smith, B.T.; Abrantes, P.; Leonardi, A.; Cerqueti, P.M.; Modorati, G.; Martinez, M. 2001: Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis American Journal of Ophthalmology 131(6): 691-698
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
González-Peñas, E.; Echeverría, H.C.; Mosquera, J.; Esteras, A.; Bruseghini, L. 2003: Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit Arzneimittel-Forschung 53(11): 786-792
Bousquet, E.; Tirendi, S.; Bonina, F.P.; Montenegro, L.; Bianchi, A.; Ciampini, N. 1992: Bioavailability of two formulations of acetylsalicylic acid gums Die Pharmazie 47(8): 607-609
Gafiţanu, E.; Dumistrăcel, I.; Antochi, S. 1991: Formulations and bioavailability of propyphenazone in lyophilized tablets Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 95(1-2): 127-128